5.38
5.38 (-0.00%)
As of Jan 14, 2022
Acumen Pharmaceuticals, Inc. [ABOS]
Source:
Company Overview
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer’s disease, or AD. Alzheimer’s disease is a progressive neurodegenerative disease of the brain that leads to loss of memory and cognitive functions and ultimately results in death.
Country | United States |
Headquarters | charlottesville, virginia |
Phone Number | 925-368-8508 |
Industry | |
CEO | Daniel OâConnell |
Website | acumenpharm.com |